Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | €82.15B | €88.80B | €93.72B | €132.51B | €76.58B | €43.99B | €69.88B | €76.94B | €70.98B | €56.69B | €73.54B |
| Research & development | €207.0M | €178.0M | €166.0M | €164.0M | €177.0M | €157.0M | €194.0M | €197.0M | €185.0M | €161.0M | €176.0M |
| Operating expenses | — | — | — | — | — | — | — | €872.0M | — | — | — |
| Operating income | €5.01B | €5.24B | €8.26B | €17.51B | €12.34B | −€3.27B | €6.43B | €9.98B | €8.01B | €2.16B | −€3.08B |
| EBITDAderived | €12.36B | €12.84B | €15.74B | €24.71B | €19.40B | €4.03B | €14.54B | €16.97B | €15.49B | €9.72B | €5.86B |
| Net income | €2.61B | €2.62B | €4.77B | €13.89B | €5.82B | −€8.63B | €148.0M | €4.13B | €3.37B | −€1.46B | −€8.78B |
| Basic EPSper diluted share | €0.78 | €0.79 | €1.41 | €3.96 | €1.61 | -€2.42 | €0.04 | €1.15 | €0.94 | -€0.41 | -€2.44 |
| Diluted EPSper diluted share | €0.78 | €0.78 | €1.40 | €3.95 | €1.60 | -€2.42 | €0.04 | €1.15 | €0.94 | -€0.41 | -€2.44 |